Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
162.12
Dollar change
+0.74
Percentage change
0.46
%
IndexDJIA, S&P 500 P/E29.07 EPS (ttm)5.58 Insider Own0.16% Shs Outstand2.41B Perf Week0.17%
Market Cap390.51B Forward P/E14.74 EPS next Y11.00 Insider Trans-1.52% Shs Float2.40B Perf Month2.03%
Income14.17B PEG6.18 EPS next Q2.63 Inst Own71.48% Short Float0.46% Perf Quarter6.58%
Sales93.02B P/S4.20 EPS this Y7.49% Inst Trans-0.39% Short Ratio1.49 Perf Half Y-0.98%
Book/sh28.57 P/B5.67 EPS next Y3.15% ROA7.62% Short Interest10.96M Perf Year6.26%
Cash/sh9.52 P/C17.03 EPS next 5Y4.70% ROE18.57% 52W Range144.95 - 175.97 Perf YTD3.43%
Dividend Est.4.80 (2.96%) P/FCF21.40 EPS past 5Y-0.27% ROI14.80% 52W High-7.87% Beta0.53
Dividend TTM4.76 (2.94%) Quick Ratio0.91 Sales past 5Y1.31% Gross Margin67.85% 52W Low11.85% ATR (14)1.90
Dividend Ex-DateFeb 16, 2024 Current Ratio1.16 EPS Y/Y TTM-17.52% Oper. Margin25.58% RSI (14)61.62 Volatility0.86% 1.21%
Employees131900 Debt/Eq0.44 Sales Y/Y TTM-2.10% Profit Margin15.23% Recom2.14 Target Price176.28
Option/ShortYes / Yes LT Debt/Eq0.39 EPS Q/Q25.42% Payout84.93% Rel Volume0.76 Prev Close161.38
Sales Surprise1.78% EPS Surprise0.39% Sales Q/Q-9.83% EarningsJan 23 BMO Avg Volume7.35M Price162.12
SMA202.35% SMA502.07% SMA2001.72% Trades Volume5,590,047 Change0.46%
Date Action Analyst Rating Change Price Target Change
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
May-30-23Resumed Citigroup Buy $185
Mar-29-23Initiated UBS Neutral $164
Mar-01-23Initiated Guggenheim Neutral $161
Nov-18-22Initiated Credit Suisse Neutral $170
Oct-18-22Initiated Barclays Equal Weight $175
Oct-14-22Reiterated BofA Securities Neutral $185 → $178
Today 08:14AM
Mar-02-24 10:42AM
Mar-01-24 03:59PM
02:44PM
Feb-29-24 05:06AM
04:47AM Loading…
04:47AM
04:19AM
Feb-28-24 06:08AM
05:49AM
05:44AM
Feb-27-24 05:45PM
Feb-26-24 12:17PM
06:00AM
Feb-24-24 11:22AM
Feb-23-24 10:02AM
05:43AM Loading…
05:43AM
Feb-22-24 11:30AM
10:09AM
08:54AM
03:48AM
Feb-21-24 05:45PM
09:12AM
09:04AM
09:00AM
09:00AM
08:30AM
06:56AM
Feb-20-24 05:00PM
04:34PM
04:25PM
06:00AM Loading…
Feb-19-24 06:00AM
05:35AM
Feb-18-24 08:58AM
Feb-17-24 01:29PM
09:51AM
Feb-15-24 06:58AM
06:39AM
Feb-14-24 04:30PM
01:19PM
12:06PM
09:44AM
Feb-13-24 02:16PM
02:10PM
06:10AM
05:21AM
Feb-12-24 04:10PM
07:30AM
Feb-10-24 01:47AM
Feb-09-24 09:00AM
Feb-08-24 03:10PM
07:06AM
05:37AM
Feb-07-24 05:25AM
Feb-06-24 01:53PM
Feb-05-24 04:00PM
03:42PM
08:30AM
08:08AM
08:01AM
06:59AM
06:02AM
Feb-04-24 08:20AM
Feb-02-24 04:10PM
Feb-01-24 09:29AM
05:30AM
Jan-31-24 04:38AM
Jan-30-24 04:44PM
03:57PM
09:22AM
07:59AM
06:15AM
05:21AM
05:06AM
Jan-29-24 09:00AM
06:26AM
06:01AM
02:53AM
Jan-28-24 01:21PM
10:20AM
Jan-27-24 10:15AM
Jan-26-24 08:32PM
12:29PM
09:30AM
Jan-25-24 09:23AM
07:19AM
Jan-24-24 01:04PM
07:00AM
06:43AM
03:42AM
02:10AM
Jan-23-24 06:28PM
04:42PM
04:22PM
04:03PM
02:30PM
01:34PM
01:23PM
01:12PM
01:09PM
12:41PM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Decker Robert JVP Corporate ControllerFeb 13Option Exercise0.00313019,059Feb 15 04:53 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13Option Exercise0.00408024,143Feb 15 04:53 PM
Forminard ElizabethExecutive VP, General CounselFeb 13Option Exercise0.0065108,576Feb 15 04:53 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13Option Exercise0.003,4700364,809Feb 15 04:53 PM
Hait WilliamSee RemarksFeb 13Option Exercise0.00834039,074Feb 15 04:53 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.009250112,550Feb 15 04:53 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13Option Exercise0.00499013,290Feb 15 04:53 PM
Swanson James D.EVP, CIOFeb 13Option Exercise0.00447014,765Feb 15 04:53 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13Option Exercise0.001,3020155,517Feb 15 04:53 PM
Wolk Joseph JExec VP, CFOFeb 13Option Exercise0.001,780069,663Feb 15 04:53 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13Option Exercise0.00651082,599Feb 15 04:53 PM
Decker Robert JVP Corporate ControllerFeb 12Option Exercise0.001,912019,269Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 12Option Exercise0.0036,6180377,239Feb 14 06:36 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 12Option Exercise0.0026,2020167,618Feb 14 06:36 PM
Forminard ElizabethExecutive VP, General CounselFeb 12Option Exercise0.002,85908,959Feb 14 06:36 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.0025,835078,699Feb 14 06:36 PM
Hait WilliamSee RemarksFeb 12Option Exercise0.008,932042,316Feb 14 06:36 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 12Option Exercise0.004,701025,081Feb 14 06:36 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 12Option Exercise0.0013,813089,014Feb 14 06:36 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 12Option Exercise0.005,736015,678Feb 14 06:36 PM
Swanson James D.EVP, CIOFeb 12Option Exercise0.005,456016,013Feb 14 06:36 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0014,9600118,644Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 09Option Exercise90.44130,96911,844,836439,283Feb 13 05:18 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09Option Exercise90.4459,3975,371,865200,813Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09Sale156.2759,3979,281,969141,416Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.003,7390143,329Feb 12 07:25 PM
Decker Robert JVP Corporate ControllerFeb 08Option Exercise0.00655017,572Feb 12 07:24 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 08Option Exercise0.001,880021,083Feb 12 07:24 PM
Hait WilliamSee RemarksFeb 08Option Exercise0.003,059034,497Feb 12 07:24 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.002,1350104,465Feb 12 07:24 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 08Option Exercise0.001,964010,943Feb 12 07:24 PM
Swanson James D.See RemarksFeb 08Option Exercise0.001,868011,111Feb 12 07:24 PM
Forminard ElizabethExecutive VP, General CounselFeb 08Option Exercise0.0097906,463Feb 12 07:24 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.003,686053,911Feb 12 07:25 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 08Option Exercise0.001,971067,905Feb 12 07:25 PM
Duato JoaquinCEO and Chairman of the BoardFeb 08Option Exercise0.005,2250310,583Feb 12 07:25 PM
Hait WilliamSee RemarksJul 26Option Exercise90.4414,6981,329,287102,445Jul 27 05:52 PM
Hait WilliamSee RemarksJul 26Sale172.0014,6982,528,05687,747Jul 27 05:52 PM
Fasolo PeterExec VP, Chief HR OfficerJul 25Sale170.3220,0003,406,498102,696Jul 27 05:52 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerJun 12Sale160.0012,4651,994,40065,934Jun 14 04:19 PM
Swanson James D.See RemarksMar 06Sale154.661,062164,1999,215Mar 08 04:16 PM